On the treatment of neurodermatitis with a monoamine oxidase inhibitor. The chemotherapy of psychosomatic illness through A-REM suppression.
D000328:Adult; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy; D003975:Diazepam / Q000627:therapeutic use; D004311:Double-Blind Method; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D008010:Lichen Planus / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy*; D010624:Phenelzine / Q000627:therapeutic use*; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D012895:Sleep, REM / Q000187:drug effects*
D010624:Phenelzine; D003975:Diazepam